D-0499-2019 Class III Terminated

Recalled by Advanced Pharma Inc. — Houston, TX

FDA drug recall D-0499-2019 was initiated by Advanced Pharma Inc. on Feb 6, 2019 and is designated Class III. Reason for recall: Superpotent Drug: product may contain concentrations of oxytocin higher than what is represented on the label. The recall status is terminated (terminated Oct 30, 2019). Affected quantity: 1460 bottles.

Recall details

Product Type
Drugs
Report Date
Feb 27, 2019
Initiation Date
Feb 6, 2019
Termination Date
Oct 30, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1460 bottles

Product description

Oxytocin 30 Units added to NS 500 mL (oxytocin and 0.9% Sodium Chloride) Injectable Solution, Approximately 503 mL Sterile single use bag, Rx only, Avella of Houston, 9265 Kirby Dr., Houston, TX 77054, NDC 42852-706-50.

Reason for recall

Superpotent Drug: product may contain concentrations of oxytocin higher than what is represented on the label.

Distribution pattern

Nationwide in the USA.

Code information

Lots: 11/27/18 3177 70650P, BUD: 02/10/2019; 11/27/18 6618 70650P, BUD: 02/10/2019; 11/28/18 7716 70650P, BUD: 02/12/19; 12/31/18 5698 70650P, BUD: 03/16/19

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0499-2019
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0499-2019. Report a data issue: hello@regdatalab.com.